Press Releases

[Dec 2006] PEGylated IFN using TheraPEG™ technology wins Research Breakthrough Award

Hammersmith Hospital NHS Trust has awarded Professor Shaunak the prestigious Research Breakthrough Award for the development of a novel medication for hepatitis C, a disease which affects over 170 million people in the developing world as well as approximately 200,000 people in the UK.

[Oct 2006] NHS at Hammersmith Hospital applauds new PEGylated IFN

Researchers motivated by the global burden of treatable disease have found a new treatment for hepatitis C that will be affordable for patients in developing countries. It will also save the NHS millions of pounds.

[Jun 2006] PolyTherics nominated Regional Finalist in UK Biotech Entrepreneur Awards 2006

PolyTherics has been nominated as one of the Regional Finalists for the UK Innovation
in Enabling Biotechnology Award 2006 at the first UK Biotechnology Entrepreneur
Awards 2006.

[May 2006] PolyTherics PEGylation technology approved by peer view in Nature Chemical Biology

PolyTherics technology for disulfide-specific insertion of 3-carbon bridge that is used as part of a linker for conjugating PEG to a protein has been approved by some of the world's leading peers.

[May 2006] Debbie Allen and Geeta Gupta join PolyTherics to enhance business development

Debbie Allen and Geeta Gupta have joined the PolyTherics team to enhance business development.